100% Quality Guarantee
PhD-Level Technical Support
Key Features

Recombinant beta-2 Adrenergic Receptor Monoclonal Antibody (AGEL6374)

SKU AGEL6374
Product Type Antibody
Reactivity Human, Rat, Mouse
Applications WB, IF, FCM
Host Species Rabbit
Clonality Monoclonal
Clone C171068
Conjugate Unconjugated
$606 - $843

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

Recombinant beta-2 Adrenergic Receptor Monoclonal Antibody

The Recombinant beta-2 Adrenergic Receptor Monoclonal Antibody is a recombinant rabbit monoclonal antibody (clone C171068) against beta-2 Adrenergic Receptor. Beta-adrenergic receptors mediate the catecholamine-induced activation of adenylate cyclase through the action of G proteins. The beta-2-adrenergic receptor binds epinephrine with an approximately 30-fold greater affinity than it does norepinephrine. Produced by recombinant technology in Rabbit hosts and purified by Protein A affinity chromatography, this Rabbit IgG antibody is reactive against Human, Mouse and Rat samples.

This antibody is suitable for WB, IF and FCM applications. It has been validated by WB analysis of A431, MCF-7, MDA-MB-231, Rat kidney, Mouse kidney, Mouse kidney, IF analysis of A431, MCF7 and FCM analysis of SH-SY5Y. The target is localized to the endosome, plasm membrane, Golgi apparatus.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose